Shots: The STOP-COVID study was conducted with a research collaboration b/w Pfizer & an ARO in Brazil, evaluating the efficacy & safety of tofacitinib (10mg, bid) + SoC vs PBO […]readmore
Tags : Covid-19 Pneumonia
Shots: The P-lll CAN-COVID trial involves assessing Ilaris (canakinumab) + SOC vs PBO + SoC in 454 patients aged 18-98yrs. with COVID-19 pneumonia and cytokine release syndrome CRS, with its […]readmore
Shots: The P-II POC study assess safety and efficacy of ANG-3777 (2.0 mg/kg, IV) + SOC vs PBO + SOC in ~100 patients in a ratio (1:1) hospitalized with confirmed […]readmore
Shots: The P-III REMDACTA study involves assessing of Actemra + remdesivir vs PBO + remdesivir in hospitalized patients with severe COVID-19 pneumonia receiving SOC with 1EPs & 2EPs as clinical […]readmore
Shots::stohthShots: Novartis to initiate P-III CAN-COVID study assessing the efficacy of canakinumab vs PBO on top of SOC in patients with COVID-19 pneumonia with its anticipated results in late summer […]readmore
Shots: The P-III COVACTA study will evaluate the safety and efficacy of Actemra/RoActemra (tocilizumab) + SOC vs PBO + SOC in adult hospitalized patients with severe COVID-19 pneumonia The study […]readmore